The majority of human papillomavirus (HPV)-associated oropharyngeal carcinomas are squamous cell carcinomas; however, there are rare reports of HPV-associated neuroendocrine carcinomas (HPV-NECs) in the upper aerodigestive tract. The aim of this study was to characterize the diagnostic features of fine-needle aspiration (FNA) cases of head and neck HPV-NEC. METHODS: Cytology cases of HPV-NEC were identified over a 3-year period from 2 institutions. Clinical, cytomorphologic, and ancillary test results were evaluated. RESULTS: Five FNA cases of HPV-NEC were identified from 4 patients with cervical lymph node metastases with primaries in the oropharynx (n = 2), nasopharynx (n = 1), and larynx (n = 1). Three cases showed mixed small cell and large cell neuroendocrine morphologies; 1 case was a small cell carcinoma, and the last case appeared as a large cell neuroendocrine carcinoma. All tumors were strongly positive for synaptophysin and p16 and negative for p63/p40. Two cases tested for INSM1 showed diffuse nuclear staining. HPV was confirmed by in situ hybridization in 4 cases, and HPV-18 was detected by polymerase chain reaction in the fifth case. Retinoblastoma (Rb) staining was moderate to weak (5/5), and p53 was weakly positive (5/5). CONCLUSIONS:
INTRODUCTION
Human papillomavirus (HPV) is now recognized as one of the primary causes of oropharyngeal carcinomas, and these tumors have seen a relative increase in incidence as tobacco-related head and neck carcinomas have declined.
1 HPV-related carcinomas have also been identified in the sinonasal tract, the second most common head and neck subsite, [2] [3] [4] and rarely in other sites of the upper aerodigestive tract (oral cavity and larynx). 5, 6 The vast majority of head and neck HPV-associated carcinomas are squamous cell carcinomas. Those HPV-associated squamous cell carcinomas arising in the oropharynx show more favorable outcomes than conventional squamous cell carcinomas. 7 Other morphologic variants of HPV-associated carcinomas, including adenocarcinoma, 8, 9 adenosquamous carcinoma, 10 multiphenotypic HPV-related sinonasal carcinoma, 3, 4 papillary squamous cell carcinoma, 11, 12 and lymphoepithelioma-like carcinoma, 13 are now recognized. There have been reports of high-grade head and neck HPV-associated
Cancer Cytopathology January 2019 neuroendocrine carcinomas (HPV-NECs), which have mainly been described in small series. [14] [15] [16] Reported sites include the oropharynx and the sinonasal tract, with both small cell and large cell morphology, and thus far, HPV subtypes 16, 18, and 33 have been identified. 14 Based on available published data, HPV-NEC shows an aggressive clinical course similar to that of high-grade neuroendocrine carcinomas in other organs such as the lungs, with distant metastases and poor survival. 14, 15, 17 Similarly to patients with HPV-associated squamous cell carcinoma, patients with HPV-NEC of the head and neck frequently develop regional lymph node metastases and are likely to undergo fine-needle aspiration (FNA); however, to date, there are no descriptions of head and neck HPV-NEC in the cytologic literature.
The aims of this study were to evaluate the clinical and cytomorphologic features of FNA cases of HPV-NEC and to investigate the immunohistochemical expression of p16, p53, and retinoblastoma (Rb) in this rare tumor.
MATERIALS AND METHODS
Cases of HPV-NEC were selected retrospectively over an approximately 3-year period (from February 1, 2015, to March 30, 2018 ) from the cytopathology files of Brigham and Women's Hospital (Boston, Massachusetts) and the University of Pittsburgh Medical Center (Pittsburgh, Pennsylvania), with approval from the respective Institutional Review Boards of each institution. FNA smears and hematoxylin and eosin-stained cell block slides, supporting immunohistochemical and other ancillary testing results, and histological follow-up results were reviewed.
Immunohistochemistry was performed on 4-µm-thick formalin-fixed, paraffin-embedded cytology cell block sections (and on a core biopsy sample for case 5) with the antibodies and condition listed in Table 1 Cancer Cytopathology January 2019 4-µm formalin-fixed, paraffin-embedded tissue sections, after pretreatment with heat and protease, with the Leica automated staining system. At the University of Pittsburgh Medical Center, HPV testing was performed with an HPV DNA probe (Enzo Diagnostics, New York, New York) that was prediluted, and the Dako GenPoint biotinylated DNA probe was used for detection (Agilent, Santa Clara, California). Punctate nuclear reactivity, indicating viral genome integration, was considered a positive result.
RESULTS
A total of 65 cases of neuroendocrine carcinoma were diagnosed in cytologic specimens from the head and neck over the 3-year study period. Of these, 5 FNA cases (7.7%) were HPV-positive, and they were all cases of metastatic HPV-NEC to cervical lymph nodes. The 5 FNA specimens originated from 4 patients (2 males and 2 females) with an age range of 39 to 79 years (mean, 62.3 years; median, 65.5 years). One patient presented with multiple nodal metastases that were separately sampled (cases 1 and 2). One patient (case 4) had a subsequent nasopharyngeal biopsy that confirmed the diagnosis of HPV-NEC, and developed liver and spinal metastases. The remaining 3 patients had presumed primary tumor sites originating in the oropharynx (n = 2) and larynx (n = 1) according to imaging studies, but all had subsequent histologic confirmation (metastasis to the kidney, cervical lymph node dissection, and concurrent core biopsy). Multimodal chemotherapy (platinumbased) was provided for all patients; in addition, 1 patient underwent nivolumab therapy (cases 1 and 2). According to the available clinical follow-up, 2 of the 4 patients (50%) died of disease: 1 patient died of disease approximately 15 months after diagnosis while on chemotherapy and nivolumab (cases 1 and 2), and the second died 8 months after initial diagnosis despite completion of chemoradiation (case 4). The clinicopathologic features of the study group are summarized in Table 2 .
All 5 FNA specimens showed cytomorphologic features suggestive of neuroendocrine differentiation: being composed of basaloid tumor cells with large, hyperchromatic nuclei, inconspicuous nucleoli, and generally scant cytoplasm. Tumor cells were variably dispersed as single cells or in loose aggregates, often with nuclear molding and palisading. Small cell morphology was present in 4 cases, with hyperchromatic nuclei having uniformly distributed chromatin, infrequent nucleoli, and molding with pencillate and angulated shapes (Fig. 1A,B) . Crush artifact was common, as were mitotic figures and single-cell apoptosis. Three FNA samples showed mixed small cell and large cell neuroendocrine features, the latter indicated by large, 
1+ 1+ 2+ 2+ Abbreviations: AWD, alive with disease; CTG, computed tomography-guided; FNA, fine-needle aspiration; HPV, human papillomavirus; IHC, immunohistochemistry; ISH, in situ hybridization; N/D, not done; PCR, polymerase chain reaction; Rb, retinoblastoma; USG, ultrasound-guided. a Cases 1 and 2 were from the same patient. b All patients had imaging studies that supported the primary tumor site.
Cancer Cytopathology January 2019 pleomorphic nuclei with variably hyperchromatic and vesicular chromatin patterns, frequent large nucleoli, and more ample cytoplasm (Figs. 2A,B and 3A,B) . The remaining case showed predominantly large cell neuroendocrine features. No cases exhibited keratinization or features suggestive of cystic changes, including histiocytes, cellular debris, and prominent inflammation.
Histologic confirmation was available for all patients (see Table 2 ). All cases having small cell carcinoma components showed typical features of tumor cells with hyperchromatic nuclei, predominantly absent nucleoli, and scant cytoplasm arranged in sheets and nests; nuclear molding, crush artifact, necrosis, and mitotic figures were frequent. For cases having mixed features of small cell and large cell neuroendocrine carcinoma (cases 1, 2, and 4) or predominantly large cell neuroendocrine features (case 3), the large cell component showed trabecular and nested growth, with larger tumor cells having vesicular nuclei, frequently prominent nucleoli, and abundant cytoplasm as well as necrosis and high mitotic activity (Fig. 3D) .
Immunohistochemical studies confirmed the expression of keratin and neuroendocrine markers and excluded squamous differentiation in all cases. Keratin was consistently positive (5/5), often in a dotlike pattern (Fig. 1C) . All tumors were negative for p63/p40 (5/5; Fig. 2C ). Synaptophysin expression was present in all cases (5/5; Figs. 1D and 2D) , whereas chromogranin was more variable (1/2). INSM1 showed diffuse nuclear staining in a two cases that were (Fig. 3C) . TTF1 was positive in 1/4 cases, and cytokeratin 20 (CK20) was negative in a single case tested. Rb staining showed weak to moderate multifocal (2+) nuclear staining (5/5 cases), and all 5 cases showed weak focal nuclear expression (1+ extent) of p53, which was consistent with a "wild-type" expression pattern as described previously 18 ( Fig. 4) . Nuclear expression of p16 
DISCUSSION
HPV-NEC is a rare variant of HPV-associated carcinomas that exhibits aggressive behavior, and may present as a high-grade neuroendocrine carcinoma of unknown primary in cervical lymph node FNA. Primary sites of tumor origin in our cohort included the oropharynx, nasopharynx, and larynx, and all patients presented with cervical lymph node metastases that underwent FNA for initial diagnosis. Although often referred to as HPV-associated small cell carcinomas, 60% of the cases in this small series showed mixed features of small cell carcinoma and large cell neuroendocrine carcinoma, and 1 case showed predominantly large cell neuroendocrine features only. These cases were uniformly negative for squamous markers and positive for neuroendocrine markers, and showed diffuse p16 nuclear expression. With additional testing, these tumors were confirmed to harbor high-risk HPV by in situ hybridization or polymerase chain reaction PCR typing. Although high-risk HPV is associated with a favorable prognosis for HPV-associated squamous cell carcinomas, we observed that patients with HPV-NEC suffered frequent early distant metastases and disease-related death, similar to prior reports illustrating an aggressive clinical course for HPV-NEC. 14-16 HPV-NEC is therefore an important entity to consider in routine cytopathologic practice, especially because affected patients frequently present with lymph node metastases and may undergo first-time diagnosis by FNA. Accurate diagnosis may dramatically alter the treatment regimen for the patient, because patients with HPV-associated squamous cell carcinomas may undergo de-escalation therapy and could be spared platinum-based chemotherapy. Specimen allocation is important for ancillary studies necessary for diagnosis. Neuroendocrine differentiation of HPV-NEC requires confirmation by immunohistochemistry, given that high-grade neuroendocrine carcinomas show overlapping features with basaloid neoplasms, including HPV-associated squamous cell carcinomas, which tend to be nonkeratinizing. All cases in our series showed synaptophysin expression and frequently dotlike keratin expression. Squamous differentiation was excluded by consistent negativity for p63 and/or p40. Immunohistochemistry for neuroendocrine markers is helpful for cytologic samples of high-grade basaloid malignancies that show some features suggestive of neuroendocrine differentiation in the setting of a suspected oropharyngeal primary, especially because synaptophysin and chromogranin are consistently negative in HPV-associated squamous cell carcinomas. 19 Furthermore, the newly described immunomarker for the Cancer Cytopathology January 2019 transcription factor INSM1 has been shown to have high sensitivity and specificity for neoplasms with neuroendocrine differentiation, including small cell carcinomas and large cell neuroendocrine carcinomas of the head and neck, 20 and would also be useful for challenging cases.
Both cases in our cohort tested for INSM1 showed diffuse nuclear positivity. Notably, HPV-NEC in the oropharynx is often associated with synchronous squamous cell carcinoma or adenocarcinoma. 14 However, no cases in our series showed components of either squamous cell carcinoma or adenocarcinoma in the limited FNA samples or on histologic follow-up. When encountering a small cell carcinoma or a large cell neuroendocrine carcinoma is encountered in a nodal metastasis, clinical correlation is necessary to exclude metastases from more common primary sites of highgrade neuroendocrine carcinomas, such as the skin, lung, and gastrointestinal tract. In addition, some round Cancer Cytopathology January 2019 cell sarcomas may show aberrant expression of keratin, synaptophysin, and chromogranin; this is notably true for alveolar rhabdomyosarcoma, which frequently presents at head and neck sites. 21, 22 Most patients in our series presented with metastases in level II or III lymph nodes, a region that favors metastases from the upper aerodigestive tract. An immunohistochemical panel is helpful in excluding morphologic mimics after confirmation of neuroendocrine differentiation and exclusion of p63/p40 expression. Negativity for p63/p40 excludes HPV-associated squamous cell carcinoma as well as other rare diagnostic considerations in the head and neck, including NUT carcinoma 23 and adamantinoma-like Ewing sarcoma. 24 TTF1
has limited discriminatory value because TTF1 expression occurs in both pulmonary and extrapulmonary small cell carcinomas. 25 TTF1 may be positive in HPV-NEC with small cell morphology, 2,14 and in our series, TTF1
was positive in 25% of tested cases. Additional immunohistochemistry studies that are helpful in excluding other entities include CK20, neurofilament protein, and polyomavirus for Merkel cell carcinoma; CK20 for salivary neuroendocrine carcinoma; MYB (or MYB FISH) for solid adenoid cystic carcinoma 26 ; S100, neuron-specific enolase, and calretinin for olfactory neuroblastoma; SMARCB1/ INI1 for basaloid examples of SMARCB1-deficient sinonasal carcinoma 27 ; mutant isocitrate dehydrogenase 1/2 for sinonasal undifferentiated carcinoma 28, 29 ; desmin and myogenin for alveolar rhabdomyosarcoma; and CD99 and NKX2.2 for Ewing sarcoma. 30 All HPV-NEC cases in our series showed diffuse nuclear p16 expression, which is considered a highly sensitive surrogate marker for high-risk HPV because p16 accumulates secondary to the integration of the E7 oncoprotein, resulting in disruption of the Rb pathway. 31 However, outside of oropharyngeal HPV-squamous cell carcinomas, p16 positivity can be seen in a wide spectrum of tumor types via other mechanisms of Rb inactivation. Nuclear p16 expression can be seen in many basaloid neoplasms that would be considered in the differential diagnosis of HPV-NEC, including pulmonary small cell carcinoma, 32, 33 small cell carcinoma of the ovary and cervix, 34 Merkel cell carcinoma, 35 and adenoid cystic carcinoma. 22, 36 In the context of a high-grade neuroendocrine carcinoma presenting as a cervical lymph node metastasis, p16 is a useful screening tool but should be followed by confirmatory HPV testing by in situ hybridization or PCR. For the patients in our series, p16 was performed selectively during clinical workup in scenarios where there was no evidence or prior history of neuroendocrine carcinoma of a specific site and/or if there was a clinically suspected upper aerodigestive tract primary; in routine practice, the rare diagnosis of HPV-NEC should be considered only after the exclusion of more likely possibilities (eg, thyroid, skin, and lung primary sites) based on clinical and immunohistochemical findings. For HPV-NEC, the role of HPV testing is most useful in assisting with identification of the primary tumor site, although an association with HPV is not prognostically meaningful in this context given their aggressive behavior. The high-risk HPV subtypes in HPV-NEC appear to be heterogeneous. 14, 16 All cases in this study tested with high-risk HPV in situ hybridization were positive, and in 1 case, HPV typing was performed by PCR and showed HPV type 18. It should be noted that not all neuroendocrine carcinomas from the upper aerodigestive tract are associated with HPV, and negative HPV test results do not exclude head and neck primary sites. 15, 37 We evaluated p53 and Rb immunohistochemical expression, as viral integration of E6 and E7 proteins also leads to inactivation of these tumor suppressors. 31 All cases showed "wild-type" patterns of p53 expression with weak staining in less than 20% of tumor cells, and Rb staining was multifocal-weak in all cases of HPV-NEC. The observed staining patterns of p53 and Rb expression are not specific, and neither marker should be considered a reliable marker for HPV-NEC or a surrogate of high-risk HPV. However, the immunohistochemical findings suggest alternative pathogenetic events in HPV-NEC than those in neuroendocrine carcinoma counterparts of other organs, specifically pulmonary small cell carcinoma, which shows a loss of the tumor suppressors Rb and TP53 38 (and resultant Rb loss of expression and either diffuse nuclear or negative [null] p53 expression by immunohistochemistry).
In conclusion, our study shows that HPV-NEC frequently shows mixed features of small cell carcinoma and large cell neuroendocrine carcinoma, which may pose diagnostic challenges in cytologic samples. Such cases typically require an immunohistochemical panel that should incorporate squamous (p63/p40) and neuroendocrine (synaptophysin and chromogranin) markers in addition to HPV markers (p16 and HPV in situ hybridization) and potentially the newer marker INSM1. Confirmatory HPV testing is helpful for metastatic high-grade neu-Cancer Cytopathology January 2019 roendocrine carcinomas in FNA specimens, particularly in cervical lymph nodes with unknown primary, and it can help clinicians to determine a potential site of origin. In addition, because many cases show large cell features, HPV-NEC may be erroneously assumed to be nonkeratinizing HPV-related squamous cell carcinoma, and this could potentially lead to undertreatment for this aggressive disease. Recognition of this entity in cytology aspirates is important because of the worse prognosis of these tumors (in comparison with the better prognosis seen in HPV-related squamous cell carcinomas), and it enables better characterization of this rare carcinoma variant.
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